Pfizer recalls some batches of blood pressure drugs over a carcinogen
- The new coronavirus may kill cancer cells and achieve a permanent cure!
- Why did the Alzheimer’s drug candidate BACE1 inhibitor fail?
- LRTI Death: Research spanning 80 years confirms for the first time
- The decline of the global antibiotic market is threatening the development of new drugs
- World first: An mRNA vaccine that can 100% protect against deadly bacterial infections is available
- The first successful use of CAR-T cells to treat severe muscle inflammation
Pfizer recalls some batches of blood pressure drugs over a carcinogen
- More than 1 million Chinese died after China quit “Zero-COVID policy”?
- Why is Vinyl chloride listed as a Class A “known human carcinogen” ?
- First human trial of HIV gene therapy: A one-time cure will be achieved if successful!
- New breakthrough in CAR-T cell therapy: Lupus erythematosus patients achieved treatment-free remission for up to 17 months
- How long can the patient live after heart stent surgery?
- First time: Systemic multi-organ recovery after death
Pfizer recalls some batches of blood pressure drugs over a carcinogen.
U.S. pharmaceutical giant Pfizer said on April 22 that it was recalling five batches of its blood pressure drug Accupril after it found elevated levels of a potential carcinogen in its blood pressure drug, Reuters just reported.
Pfizer said it has not identified any reports of adverse events related to the recalled batches. The drugs were sold in the U.S. and Puerto Rico from December 2019 to April 2022.
Pfizer Canada also recalled all batches of three doses of Accupril on Thursday after finding the same impurity above acceptable levels.
Pfizer said nitrosamines have been found in the drug, but there is no immediate risk to patients taking the drug.
Nitrosamines are common in water and food, but chronic intake of nitrosamines above acceptable levels increases the risk of cancer.
Pfizer last month also recalled some batches and two authorized cheaper versions of another blood pressure drug, Accuretic, because of a possible carcinogen in it.
News on March 27
On March 21, Pfizer voluntarily recalled 3 commonly used antihypertensive drugs because of a notice of voluntary recall of drugs.
Half a month ago, on March 4, Pfizer Canada recalled the same blood pressure lowering drug in the Canadian market. The reasons for the two recalls are also the same.
In the past five years, Pfizer has recalled a total of 14 times across the United States, involving 16 drugs, and has repeatedly been caught in the “recall door”. of global pharmaceutical companies continue to face doubts about the quality and safety of medicines.
(source:internet, reference only)
Disclaimer of medicaltrend.org
